Publications by authors named "J van Tol"

Claim this Profile
R
Response to the letter to the Editor concerning "Tibial tubercle apophyseal pain and maturation in youth elite football".
Nienke van Engelen, Johannes L Tol, Gustaaf Reurink

J Sci Med Sport· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete responders in patients with HER2-positive metastatic breast cancer: a real-world SONABRE study.
Nan Ding, Renee Visserman, Sandra M E Geurts, Jolien Tol, Birgit E P J Vriens

Breast· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial.
Noor Wortelboer, Seamus Kent, Inge R Konings, Annemiek van Ommen-Nijhof, Vincent van der Noort, Jolien Tol

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in incidence of post-induction hypotension depending on the time of day: a post-hoc propensity score matched analysis.
Johan T M Tol, Arjen J G Meewisse, Sijm H Noteboom, Ward H van der Ven, Vincent C Kurucz

J Clin Anesth· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial.
Noor Wortelboer, Seamus Kent, Hedwig M Blommestein, Annemiek van Ommen-Nijhof, Vincent van der Noort, Jolien Tol

J Natl Cancer Inst· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis